TFA
UTHR icon

Toth Financial Advisory’s United Therapeutics UTHR Stock Holding History

Toth Financial Advisory’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Buy
50
+48
+2,400% +$27K ﹤0.01% 465
2026
Q1 		$1.19K Sell
2
-44
-96% -$21.9K ﹤0.01% 789
2025
Q4 		$22.4K Buy
+46
New +$21.4K ﹤0.01% 468
2025
Q3 		– Sell
-10
Closed -$2.87K – 838
2025
Q2 		$2.87K Sell
10
-1,300
-99% -$389K ﹤0.01% 606
2025
Q1 		$404K Sell
1,310
-1,760
-57% -$603K 0.05% 170
2024
Q4 		$1.08M Buy
3,070
+180
+6% +$66.2K 0.13% 121
2024
Q3 		$1.04M Buy
2,890
+1,590
+122% +$537K 0.12% 121
2024
Q2 		$414K Buy
+1,300
New +$344K 0.05% 163

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Toth Financial Advisory's UTHR Position: Q2 2026 in Review

Toth Financial Advisory increased its United Therapeutics (UTHR) stake by 2,400% in Q2 2026, buying an estimated $27K and bringing the position to 50 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

Toth Financial Advisory first reported a position in UTHR in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.08M in Q4 2024. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Toth Financial Advisory held 50 shares of United Therapeutics worth $27.1K as of Q2 2026.
  • Toth Financial Advisory bought 48 United Therapeutics shares in Q2 2026, an estimated $27K.
  • United Therapeutics made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #465 holding.
  • Toth Financial Advisory first reported a position in United Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Toth Financial Advisory's United Therapeutics position peaked at $1.08M in Q4 2024.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.